Efforts are being made by researchers at the University of Texas Medical Branch at Galveston to find out if the drug, Digibind, presently used by heart patients can be used for delaying delivery in expectant mothers with severe preeclampsia.

If these efforts are met with success, this would indeed be a groundbreaking study offering hopes to thousands of women who are affected by this life-threatening disorder.

From News-Medical.Net:

“Preeclampsia is the No. 1 killer of pregnant women in the world, and there is no cure except delivery,” said Dr. George Saade, chief of maternal–fetal medicine at UTMB. “When it is severe and occurs early in the pregnancy, delivery in order to protect the mother results in a premature baby. That’s why this study is important, because if the medication works, then we can protect the mom while allowing the baby to grow and develop without delivering early.”

The clinical trial will test whether Digibind reverses or prevents the abnormalities that occur with preeclampsia and allows the fetus to remain in the womb longer. This would give doctors more time to administer steroids to prevent respiratory complications in premature births and reduce the need for costly and lengthy neonatal intensive care.

Dr. Nicole Ruddock, the study’s principal investigator and an instructor in UTMB’s Department of Obstetrics and Gynecology, said that this study is truly groundbreaking as there is no treatment for preeclampsia presently.

Bookmark It

Hide Sites

Tags: Digibind, preeclampsia, steroids

Posted in Steroid Cycles, Steroids and Anabolic Steroids, buy steroids, steroid nation